Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026)
Ginkgo Bioworks Holdings (DNA) reported Amortizatization of Intangibles of $7.1 million for Q1 2026, down 3.59% on a YoY basis from $7.4 million in Q1 2025, and down 6.8% quarter-over-quarter from $7.6 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported Amortizatization of Intangibles for 5 years, with the latest figure at $7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 3.59% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $29.8 million (changed 0.07% YoY), and the FY2025 full-year result was $30.1 million, up 7.07% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $7.1 million, down from $7.6 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $10.9 million in Q3 2022, with the low at $3.7 million in Q4 2023.
- Historically, Amortizatization of Intangibles has averaged $7.4 million across 5 years, with a median of $7.5 million in 2025.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles plunged 48.95% — and 2024, when it soared 103.26%.
- Ginkgo Bioworks Holdings' Amortizatization of Intangibles stood at $7.2 million in 2022, then slumped by 48.95% to $3.7 million in 2023, then soared by 103.26% to $7.5 million in 2024, then increased by 2.1% to $7.6 million in 2025, then retreated by 6.8% to $7.1 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $7.1 million (Q1 2026), $7.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 466.98 Mn | 466.98 Mn | 16.38 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.11 Mn |
| Mar 31, 2026 | 7.11 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Dec 31, 2025 | 7.63 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Jun 30, 2025 | 7.49 Mn |
| Jun 30, 2025 | 7.49 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Sep 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Dec 31, 2023 | 3.68 Mn |